If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
312.00    0.00 (0.00%)
Bid:
310.00
Ask:
314.00
Spread: 4.00 (1.29%)
Market Cap: £39.59m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Pre-Close Trading Statement

19 Jan 2009 07:00

RNS Number : 8288L
BrainJuicer Group PLC
19 January 2009
 



Press Release

 19 January 2009

BrainJuicer Group PLC

("BrainJuicer" or "the Company")

Pre-Close Trading Statement 

Strong Full Year - Results Ahead of Expectations

BrainJuicer Group PLC, (AIM: BJU), a leading global online market research agency, is pleased to announce the following pre-close trading statement for the financial year ended 31 December 2008.  

Highlights:

Results ahead of market expectations 
Reported revenues of over £9m, (an increase of over 40%)
Operating profit up by 45% to over £1.2m 

Clients increased from 115 to 140 and from 19 to 24 of world's top 200 companies (FTSE Global 500 2008)

Innovative new products grew by more than 50% and now account for over 40% of revenue

 

The Company's revenue growth (which was entirely organic) reflected strong trading performance across each of the groups' regions, and enabled the Company to continue investing in its technology platform and to start paying dividends (the 2008 interim dividend was 0.5p per share and the Company paid an additional special dividend of 1.7p per share).

2008 saw the Company increase its geographic expansion, opening an office in Switzerland and signing a strategic licensing agreement in Australia, as well as continuing to grow its existing businesses in the UK, US and Holland. The Company has continued to innovate and deliver new and creative products to its blue chip client base. The Company announces today that it is continuing its new product development and geographic expansion by launching a Research Community product and establishing a presence in Germany and Canada, both important territories in terms of existing and potential multinational clients.

The Company's research community product (the JuicyBrains Community) is an innovative offering, and has been successfully piloted with 3 large multinationals. Research Communities are one of the fastest growing sectors in the industry.

On the back of strong demand from multinational clients, the Company is opening an office in Germany, the 3rd largest research market in the world [ESOMAR Industry Report 08]. The company has appointed Jonathan Gable as Managing Director of BrainJuicer Germany, based in Hamburg.  Jonathan has over 15 years of market research and marketing experience predominantly in multinational FMCG organisations (including Colgate-Palmolive and General Mills).

The Company has also signed a licence agreement with High Level Research Inc (HIGHLevel), a new Canadian market research agency under which it will provide the Company's products in this region. It has also been agreed that the Company will acquire HIGHLevel once pre-agreed financial targets have been achieved for a total consideration of C$900,000, providing that such targets are met by 2013. HIGHLevel is headed by William (Bill) Ratcliffe, PhD, who previously managed Millward Brown Canada and most recently served as Global Head of Consumer Insights at MediaCom. John KearonCEO of BrainJuicer, commented: "In the current economic conditions, we are pleased to have delivered ahead of expectations and to announce the launch of another innovative product and further geographic expansion of the business to service our growing number of large multinational clients. We are also delighted to welcome research professionals of the calibre of Jonathan to our team and Bill to the BrainJuicer network We believe HIGHLevel will be a great partner and we're looking forward to working closely with Bill as the relationship develops."

A full update will be provided at the Company's Final Results on 19th March 2009. An analyst briefing, given by John Kearon (CEO) and James Geddes (CFO), will be given at 9.30am on 19th March 2009 at Abchurch Communications, 5th Floor, 100 Cannon Street, London, EC4N 6EU.

- Ends -

For further information, please contact:

 

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000 

James Geddes, Chief Financial Officer

www.brainjuicer.com

Canaccord Adams Limited

Mark Williams / Adria Da Breo Richards

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

UK media enquiries:

Abchurch Communications

Tel: +44 (0) 20 7398 7700

Heather Salmond / Jack Ballantyne

Tel: +44 (0) 20 7398 7714

jack.ballantyne@abchurch-group.com

www.abchurch-group.com 

Notes to Editors

BrainJuicer carries out quantitative online research using innovative, bespoke software to produce insightful market research for large, multinational companies, including 24 of the world's top 200 companies (FT 500 September 2008).

BrainJuicer operates in a growing sector of the US$25bn global research market, namely quantitative online research. BrainJuicer's main competitors are large traditional market research providers who have dominated the market for off-line market research, such as AC Nielsen, Millward Brown, Research International, IPSOS, GfK and Taylor Nelson Sofres.

Whilst the largest traditional research companies have developed their own online capability, BrainJuicer has a number of key attributes which have contributed to it achieving rapid growth and winning contracts with prestigious clients, including:

• Research platform that delivers greater diagnostic insight. BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level of qualitative diagnostic insight within quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services.

• Speed. BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services.

• A scaleable online-only business model. Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model.

To date the Group has conducted projects in over 50 countries and more than 30 languages and has established a presence in the UK, the Netherlands, the USSwitzerland and Germany.

Further information on BrainJuicer can be found at www.brainjuicer.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFLLLEITLIA
Date   Source Headline
12th Jan 202212:30 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.